Concord Biotech IPO: All you need to know
NEW DELHI: Concord Biotech, backed by Rare Enterprises, has announced the price band for its initial public offering (IPO) at Rs 705-741 per share, aiming to raise Rs 1,550 crore.
The Times of India ·